Chemodynamic PtMn Nanocubes for Effective Photothermal ROS Storm a Key Anti-Tumor Therapy in-vivo
- PMID: 38832334
- PMCID: PMC11146616
- DOI: 10.2147/IJN.S455936
Chemodynamic PtMn Nanocubes for Effective Photothermal ROS Storm a Key Anti-Tumor Therapy in-vivo
Abstract
Background: Chemodynamic therapy (CDT) is a new treatment approach that is triggered by endogenous stimuli in specific intracellular conditions for generating hydroxyl radicals. However, the efficiency of CDT is severely limited by Fenton reaction agents and harsh reaction conditions.
Methods: Bimetallic PtMn nanocubes were rationally designed and simply synthesized through a one-step high-temperature pyrolysis process by controlling both the nucleation process and the subsequent crystal growth stage. The polyethylene glycol was modified to enhance biocompatibility.
Results: Benefiting from the alloying of Pt nanocubes with Mn doping, the structure of the electron cloud has changed, resulting in different degrees of the shift in electron binding energy, resulting in the increasing of Fenton reaction activity. The PtMn nanocubes could catalyze endogenous hydrogen peroxide to toxic hydroxyl radicals in mild acid. Meanwhile, the intrinsic glutathione (GSH) depletion activity of PtMn nanocubes consumed GSH with the assistance of Mn3+/Mn2+. Upon 808 nm laser irradiation, mild temperature due to the surface plasmon resonance effect of Pt metal can also enhance the Fenton reaction.
Conclusion: PtMn nanocubes can not only destroy the antioxidant system via efficient reactive oxygen species generation and continuous GSH consumption but also propose the photothermal effect of noble metal for enhanced Fenton reaction activity.
Keywords: Fenton reaction; Mn-doping; chemodynamic therapy; noble metal; photothermal effect.
© 2024 Wang et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures





Similar articles
-
Manganese-doped liquid metal nanoplatforms for cellular uptake and glutathione depletion-enhanced photothermal and chemodynamic combination tumor therapy.Acta Biomater. 2025 Jan 1;191:369-385. doi: 10.1016/j.actbio.2024.11.010. Epub 2024 Nov 9. Acta Biomater. 2025. PMID: 39522626
-
A Combination of Biocatalysis and Fenton-Like Reaction Induced OH• Burst for Cascade Amplification of Cancer Chemodynamic Therapy.Mol Pharm. 2024 Jul 1;21(7):3434-3446. doi: 10.1021/acs.molpharmaceut.4c00143. Epub 2024 May 23. Mol Pharm. 2024. PMID: 38781419
-
Copper-doped PDA nanoparticles with self-enhanced ROS generation for boosting photothermal/chemodynamic combination therapy.Biomater Sci. 2025 Jul 8;13(14):3903-3914. doi: 10.1039/d5bm00418g. Biomater Sci. 2025. PMID: 40478243
-
Chemodynamic Therapy: Tumour Microenvironment-Mediated Fenton and Fenton-like Reactions.Angew Chem Int Ed Engl. 2019 Jan 21;58(4):946-956. doi: 10.1002/anie.201805664. Epub 2018 Nov 20. Angew Chem Int Ed Engl. 2019. PMID: 30048028 Review.
-
Recent advances in multifunctional nanomaterials for photothermal-enhanced Fenton-based chemodynamic tumor therapy.Mater Today Bio. 2022 Jan 4;13:100197. doi: 10.1016/j.mtbio.2021.100197. eCollection 2022 Jan. Mater Today Bio. 2022. PMID: 35036895 Free PMC article. Review.
Cited by
-
Downregulation of chemokine (C‑C motif) ligand 5 induced by a novel 8‑hydroxyquinoline derivative (91b1) suppresses tumor invasiveness in esophageal carcinoma.Int J Mol Med. 2024 Dec;54(6):111. doi: 10.3892/ijmm.2024.5435. Epub 2024 Oct 4. Int J Mol Med. 2024. PMID: 39364750 Free PMC article.
References
-
- Li Z, Zou J, Chen X. In Response to Precision Medicine: current Subcellular Targeting Strategies for Cancer Therapy. Adv. Mater. 2023;35(21):2209529. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical